drugset / Trial / NCT05905354
Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive
NaSequentialOpen-labelTreatment
Summary
This is an open-label exploratory clinical study. The main objective is to explore the immunogenicity of HPV therapeutic DNA vaccine NWRD08.
Timeline
- Start
- 2022-03-07
- Primary completion
- 2024-06-30
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NWRD08 | Vaccine | 2 mg | Intramuscular |
| Subject | NWRD08 | Vaccine | 6 mg | Intramuscular |